Cargando…
Statin-Induced Rhabdomyolysis Associated With Transjugular Intrahepatic Portosystemic Shunt Placement
Rhabdomyolysis is a known rare and potentially lethal complication of statin use. This toxic effect is potentiated by alterations in hepatic physiology in patients with cirrhosis. Transjugular intrahepatic portosystemic shunt placement has the potential to further compound this effect; yet, examples...
Autores principales: | Swei, Eric C., Brar, Anantnoor K., Rice, Jonathan D., Kim, Ike I., Knez, Virginia M., Doe, Christopher F., Forman, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287266/ https://www.ncbi.nlm.nih.gov/pubmed/35919670 http://dx.doi.org/10.14309/crj.0000000000000774 |
Ejemplares similares
-
Biliary Obstruction After Transjugular Intrahepatic Portosystemic Shunt Placement
por: Patel, Feenalie, et al.
Publicado: (2021) -
The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014) -
Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis
por: Liu, Jiacheng, et al.
Publicado: (2019) -
Advanced portal venous access techniques for transjugular intrahepatic portosystemic shunt placement
por: Partovi, Sasan, et al.
Publicado: (2021) -
Transjugular Intrahepatic Portosystemic Shunt Placement: Effects on Nutritional Status in Cirrhotic Patients
por: de Felice, Ilaria, et al.
Publicado: (2023)